Can Photobiomodulation Help Protect Aging Eyes?
The ability to see clearly shapes nearly every part of daily life.
Reading a book, recognizing a familiar face, driving, preparing a meal, or moving confidently through a room all depend on the retina, the light-sensitive tissue at the back of the eye.
As we age, this tissue can become more vulnerable to degeneration. A recent clinical trial suggests that photobiomodulation may have a role to play in supporting retinal health and preserving visual function over time.¹
Why the Retina Needs So Much Energy
Retinal tissue requires enormous amounts of cellular energy.
Each time light enters the eye, the retina helps translate it into signals the brain can understand. This continuous work places significant demands on the cells and their mitochondria, the structures responsible for producing much of the energy cells need to function.
Mitochondrial dysfunction is associated with degenerative eye disease. Researchers are therefore studying whether photobiomodulation can support processes involved in cellular energy production, metabolic stability, and protection within the retina.¹
The biology is more complex than simply “recharging” the eye. Still, the connection between photobiomodulation, mitochondrial health, and vision helps explain why light therapy for aging eyes has become an important area of research.
What Is Dry Age-Related Macular Degeneration?
Dry age-related macular degeneration affects the macula, the central part of the retina responsible for detailed vision. People living with the condition may experience blurry or distorted central vision, difficulty reading, trouble recognizing faces, reduced ability to see fine details, and greater difficulty in low light.
The condition often progresses gradually. In its more advanced stages, it can lead to geographic atrophy, where areas of retinal tissue deteriorate permanently. Because damaged retinal tissue is difficult to restore, researchers are particularly interested in therapies that may help support the eye earlier in the degenerative process.
What the 24-Month Study Found
The clinical trial followed 100 people, representing 148 eyes with dry age-related macular degeneration. Participants were randomly assigned to receive either multiwavelength photobiomodulation or a reduced-dose sham treatment. Treatment was provided in recurring series, and participants were followed for two years.¹
A recent 24-month clinical trial found that photobiomodulation was associated with improved visual acuity and a lower rate of progression to geographic atrophy in people with dry age-related macular degeneration.¹ At 21 months, the photobiomodulation group gained an average of 6.2 letters on a standardized vision chart.
Among treated eyes:
- 61.5% gained at least five letters
- 23.1% gained at least ten letters
- 4.4% gained at least fifteen letters
The average improvement was largely maintained through the final 24-month assessment.¹
A Possible Change in the Disease’s Trajectory
The eye-chart results were encouraging, but the most compelling finding may have been the rate at which the condition progressed. At 24 months, geographic atrophy had developed in:
- 6.8% of photobiomodulation-treated eyes
- 24% of eyes in the sham-treatment group
Geographic atrophy is associated with permanent loss of retinal tissue and vision. The difference between the two groups suggests photobiomodulation may have influenced more than short-term visual performance. It may also have influenced the trajectory of the degenerative condition itself.¹
This finding should be interpreted carefully. The development of geographic atrophy was not the study’s primary outcome, and the researchers described several of the anatomical findings as exploratory. Even so, the difference is meaningful enough to warrant continued investigation.
Vision Is Also About Quality of Life
Changes in vision are not limited to the letters someone can read on a chart. Vision affects independence, social connection, confidence, and the ability to participate in everyday activities.
In the study, the photobiomodulation group maintained vision-related quality of life more successfully. The sham group experienced greater difficulty in areas such as near vision, reading newspapers, visiting with people, and completing daily activities.¹
Light therapy may not only support how the eyes function today. Emerging research suggests it could also help preserve retinal function over time.
Is Photobiomodulation Safe for the Eyes?
The researchers reported no signs of phototoxicity, meaning they found no evidence that the light treatment damaged the retina.
The overall rate of eye-related adverse events was similar between the treatment and sham groups. Treatment-related adverse events were uncommon, and no serious adverse events were considered to have been caused by the treatment.¹
However, this does not mean every red light device or treatment approach is appropriate for the eyes. The research used a carefully controlled clinical protocol involving specific wavelengths, doses, timing, and treatment intervals. The findings should not automatically be applied to home devices or unrelated photobiomodulation treatments.
Anyone experiencing macular degeneration, unexplained vision changes, or another retinal condition should continue working closely with an optometrist or ophthalmologist.
What This Research May Mean for Aging Eyes
Photobiomodulation is not a replacement for regular eye examinations, prescribed treatments, nutritional support, or monitoring by an eye-care professional.
That being said, it does offer an intriguing new direction for research.
Photobiomodulation may have influenced the trajectory of a degenerative condition. Rather than focusing only on function after retinal tissue has been lost, researchers are exploring whether cellular health can be supported earlier.
For people concerned about aging eyes, that possibility carries a quiet kind of hope: preserving more of the vision that connects us to the people, places, and details of everyday life.
We’ll continue following the science as researchers learn more about photobiomodulation and retinal health.
🌿
Curious about how photobiomodulation may fit into your broader wellness plan? The RegenClinic team is always happy to answer your questions.
Call or text us at 250-208-4218
Email: hello@regenclinic.ca